Inflammation exerts a nonrandom risk in the acquisition and progression of the MPN: Insights from a Mendelian randomization study

Podobne zapisy

• Applied genomics in MPN presentation
  od: Moliterno, Alison R., i wsp.
  Wydane: (2020)
• Sex determines the presentation and outcomes in MPN and is related to sex-specific differences in the mutational burden
  od: Karantanos, Theodoros, i wsp.
  Wydane: (2020)
• AKNA: Another AT-hook transcription factor “hooking-up” with inflammation
  od: Moliterno, Alison R, i wsp.
  Wydane: (2011)
• The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN
  od: Spivak, Jerry L., i wsp.
  Wydane: (2021)
• Assessing the cardiovascular risk of hormonal therapy in patients with prostate cancer
  od: Karantanos, Theodoros, i wsp.
  Wydane: (2016)